A significant negative association was found between aerobic exercise intensity and fatigue reduction .
A peak effect was found for moderate-intensity aerobic exercise for improving walking endurance .
No dose-response relationship was found between exercise and markers of inflammation or exercise duration and outcomes .
Rates of adherence were typically high and few adverse events were reported .
Exercise is safe , reduces fatigue and increases endurance in cancer survivors .
QUESTION Is there a dose-response effect of exercise on inflammation , fatigue and activity in cancer survivors ?
The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
The European Cancer Anaemia Survey ( ECAS ) was conducted to prospect ively evaluate the prevalence , incidence and treatment of anaemia ( haemoglobin < 12.0 g/dL ) in European cancer patients , including the relationship of mild , moderate and severe anaemia to performance status . Patients were evaluated for up to 6 months . Data ( N=15367 ) included demographics , tumour type , performance status , haemoglobin levels , cancer treatments and anaemia treatments . Prevalence of anaemia at enrollment was 39.3 % ( haemoglobin < 10.0 g/dL , 10 % ) , and 67.0 % during the survey ( haemoglobin < 10.0 g/dL , 39.3 % ) . Low haemoglobin levels correlated significantly with poor performance status . Incidence of anaemia was 53.7 % ( haemoglobin < 10.0 g/dL , 15.2 % ) . Anaemia was treated in 38.9 % of patients ( epoetin , 17.4 % ; transfusion , 14.9 % ; and iron , 6.5 % ) . Mean haemoglobin to initiate anaemia treatment was 9.7 g/dL. Anaemia prevalence and incidence in cancer patients are high . Anaemia significantly correlates with poor performance status and many anaemic patients are not treated
A significant negative association was found between aerobic exercise intensity and fatigue reduction .
A peak effect was found for moderate-intensity aerobic exercise for improving walking endurance .
No dose-response relationship was found between exercise and markers of inflammation or exercise duration and outcomes .
Rates of adherence were typically high and few adverse events were reported .
Exercise is safe , reduces fatigue and increases endurance in cancer survivors .
QUESTION Is there a dose-response effect of exercise on inflammation , fatigue and activity in cancer survivors ?